Steven B Ketchum
CIK 1289884 · EVP, Chief Scientific Officer · last filed 2026-02-03
Steven B Ketchum is an EVP, Chief Scientific Officer who has filed 87 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for AMRN, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$24.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $623.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$623.0K
3
87
-$24.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMRN | EVP, Chief Scientific Officer | 40,879 | $15.24 | $623.0K | -$24.80M | 69 | 2026-02-03 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | Director | 86,378 | $18.62 | $1.61M | $43.5K | 17 | 2020-07-01 |
| Viracta Therapeutics, Inc. (SNSSD) Delisted | Sr. Vice President, R & D | 72,921 | — | — | $0 | 1 | 2011-03-02 |
Recent Filings
87 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | AMRN | Mixed | +1,882 | -$35.4K | EDGAR |
| 2026-01-06 | AMRN | Mixed | +1,647 | -$28.5K | EDGAR |
| 2025-01-31 | AMRN | Mixed | +76,161 | -$58.0K | EDGAR |
| 2025-01-10 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2024-08-01 | AMRN | Mixed | +12,120 | -$9.2K | EDGAR |
| 2024-02-09 | AMRN | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | AMRN | Mixed | +38,313 | -$51.1K | EDGAR |
| 2024-01-12 | AMRN | Mixed | +23,230 | -$27.4K | EDGAR |
| 2024-01-08 | AMRN | Mixed | +6,836 | -$6.7K | EDGAR |
| 2024-01-02 | AMRN | Mixed | +71,291 | $20.5K | EDGAR |